Next Article in Journal
The Effects of a Low-Carbohydrate Diet vs. a Low-Fat Diet on Novel Cardiovascular Risk Factors: A Randomized Controlled Trial
Next Article in Special Issue
Nutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin Resistance
Previous Article in Journal
Food Processing and the Mediterranean Diet
Previous Article in Special Issue
Hepatic Steatosis as a Marker of Metabolic Dysfunction

Phytosterols, Phytostanols, and Lipoprotein Metabolism

University of Helsinki and Helsinki University Central Hospital, Internal Medicine, Biomedicum Helsinki C 4 22, P.O. BOX 700, 00029 HUS, Helsinki, Finland
University of Helsinki and Helsinki University Central Hospital, Heart and Lung Center, P.O. BOX 700, 00029 HUS, Helsinki, Finland
Author to whom correspondence should be addressed.
Nutrients 2015, 7(9), 7965-7977;
Received: 7 August 2015 / Revised: 8 September 2015 / Accepted: 11 September 2015 / Published: 17 September 2015
(This article belongs to the Special Issue Lipoprotein Metabolism and Atherosclerosis)
The efficacy of phytosterols and phytostanols added to foods and food supplements to obtain significant non-pharmacologic serum and low density lipoprotein (LDL) cholesterol reduction is well documented. Irrespective of age, gender, ethnic background, body weight, background diet, or the cause of hypercholesterolemia and, even added to statin treatment, phytosterols and phytostanols at 2 g/day significantly lower LDL cholesterol concentration by 8%–10%. They do not affect the concentrations of high density lipoprotein cholesterol, lipoprotein (a) or serum proprotein convertase subtilisin/kexin type 9. In some studies, phytosterols and phytostanols have modestly reduced serum triglyceride levels especially in subjects with slightly increased baseline concentrations. Phytosterols and phytostanols lower LDL cholesterol by displacing cholesterol from mixed micelles in the small intestine so that cholesterol absorption is partially inhibited. Cholesterol absorption and synthesis have been carefully evaluated during phytosterol and phytostanol supplementation. However, only a few lipoprotein kinetic studies have been performed, and they revealed that LDL apoprotein B-100 transport rate was reduced. LDL particle size was unchanged, but small dense LDL cholesterol concentration was reduced. In subjects with metabolic syndrome and moderate hypertriglyceridemia, phytostanols reduced not only non- high density lipoprotein (HDL) cholesterol concentration but also serum triglycerides by 27%, and reduced the large and medium size very low density lipoprotein particle concentrations. In the few postprandial studies, the postprandial lipoproteins were reduced, but detailed studies with apoprotein B-48 are lacking. In conclusion, more kinetic studies are required to obtain a more complete understanding of the fasting and postprandial lipoprotein metabolism caused by phytosterols and phytostanols. It seems obvious, however, that the most atherogenic lipoprotein particles will be diminished. View Full-Text
Keywords: cholesterol absorption; LDL; phytosterol; phytostanol cholesterol absorption; LDL; phytosterol; phytostanol
MDPI and ACS Style

Gylling, H.; Simonen, P. Phytosterols, Phytostanols, and Lipoprotein Metabolism. Nutrients 2015, 7, 7965-7977.

AMA Style

Gylling H, Simonen P. Phytosterols, Phytostanols, and Lipoprotein Metabolism. Nutrients. 2015; 7(9):7965-7977.

Chicago/Turabian Style

Gylling, Helena, and Piia Simonen. 2015. "Phytosterols, Phytostanols, and Lipoprotein Metabolism" Nutrients 7, no. 9: 7965-7977.

Find Other Styles

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop